BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Acharya SK, Bopanna S. Hepatocellular Carcinoma Screening and Nonalcoholic Fatty Liver Disease: How is it Different? J Clin Exp Hepatol 2020;10:518-24. [PMID: 33029058 DOI: 10.1016/j.jceh.2020.04.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Duseja A, Dhiman RK, Premkumar M. Nonalcoholic Fatty Liver Disease: Lessons Learnt in the Last Five Years. J Clin Exp Hepatol 2021;11:159-62. [PMID: 33746439 DOI: 10.1016/j.jceh.2020.07.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Chang T, Hsu N, Chen S, Hsu I, Lee M, Lu S. Non-B, Non-C Hepatocellular Carcinoma in an HBV- and HCV-Endemic Area: A Community-Based Prospective Longitudinal Study. Viruses 2022;14:984. [DOI: 10.3390/v14050984] [Reference Citation Analysis]